Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis

Mitsunori Ikeda1, Hisatake Matsumoto1, Hiroshi Ogura1

  • 1Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Journal of Critical Care
|August 28, 2017
PubMed

Insights

Syndecan-1, a marker of endothelial dysfunction in sepsis, can predict the development of disseminated intravascular coagulation (DIC). Elevated syndecan-1 levels in sepsis patients correlate with disease severity and mortality.

Area of Science:

  • Biomedical research
  • Sepsis pathophysiology
  • Endothelial biology

Background:

  • Sepsis involves endothelial dysfunction, a key factor in disseminated intravascular coagulation (DIC).
  • Syndecan-1 is a crucial endothelial component influencing endothelial function.

Purpose of the Study:

  • To evaluate syndecan-1 as a predictive marker for DIC in sepsis patients.
  • To assess the relationship between syndecan-1 levels and sepsis severity, DIC development, and mortality.

Main Methods:

  • Prospective observational study of 39 sepsis patients and 15 healthy controls.
  • Serial analysis of hemostatic, anticoagulant, fibrinolytic, endothelial, and inflammatory markers.
  • Evaluation of clinical data including APACHE II, SOFA, and DIC scores, and 28-day mortality.

Main Results:

  • Septic patients showed significantly higher syndecan-1 levels than controls.
  • Non-survivors had higher syndecan-1 levels than survivors.
  • Syndecan-1 levels correlated with disease severity scores (APACHE II, SOFA, DIC), hemostatic markers, and inflammatory markers (IL-1β, IL-8).
  • Syndecan-1 demonstrated strong discriminative power for predicting DIC development (AUC=0.79) and mortality (AUC=0.85).

Conclusions:

  • Syndecan-1 levels are associated with illness severity, mortality, and DIC development in sepsis.
  • Syndecan-1 shows potential as a predictive biomarker for DIC in sepsis.
Abstract

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.8K
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.1K